3.30Open1.18Pre Close87 Volume125 Open Interest76.00Strike Price27.67KTurnover1908.60%IV0.21%PremiumNov 22, 2024Expiry Date3.17Intrinsic Value100Multiplier-2DDays to Expiry0.15Extrinsic Value100Contract SizeAmericanOptions Type-0.8822Delta0.0748Gamma21.58Leverage Ratio-194.9329Theta0.0000Rho-19.04Eff Leverage0.0003Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet